Literature DB >> 22899291

Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.

Darya Buehler1, Heather Hardin, Weihua Shan, Celina Montemayor-Garcia, Patrick S Rush, Sofia Asioli, Herbert Chen, Ricardo V Lloyd.   

Abstract

Epithelial-mesenchymal transition is an important mechanism of epithelial tumor progression, local invasion and metastasis. The E-cadherin (CDH1) repressor SLUG (SNAI2) and the basic helix-loop-helix transcription factor TWIST1 inhibit CDH1 expression in poorly differentiated malignancies as inducers of epithelial-mesenchymal transition. Epithelial-mesenchymal transition has been implicated in progression from well to poorly differentiated/anaplastic thyroid carcinoma but the expression of SNAI2 and TWIST1 proteins and their phenotypic association in human thyroid cancers has not been extensively studied. We examined the expression of SNAI2, TWIST1 and CDH1 by immunohistochemistry in a panel of well-differentiated and anaplastic thyroid cancers and by qRT-PCR in thyroid cell lines. Ten normal thyroids, 33 follicular adenomas, 56 papillary thyroid carcinomas including 28 follicular variants, 27 follicular carcinomas and 10 anaplastic thyroid carcinomas were assembled on a tissue microarray and immunostained for SNAI2, TWIST1 and CDH1. Most (8/10) anaplastic thyroid carcinomas demonstrated strong nuclear immunoreactivity for SNAI2 with associated absence of CDH1 in 6/8 cases (75%). TWIST1 was expressed in 5/10 anaplastic thyroid carcinomas with absence of CDH1 in 3/5 (60%) cases. These findings were confirmed in whole sections of all anaplastic thyroid carcinomas and in a separate validation set of 10 additional anaplastic thyroid carcinomas. All normal thyroids, follicular adenomas, papillary and follicular thyroid carcinomas were negative for SNAI2 and TWIST1 (P<0.0001) and all showed strong diffuse immunoreactivity for CDH1 (P=0.026). Expression of SNAI2, TWIST1 and CDH1 mRNA varied in a normal thyroid, papillary carcinoma and two anaplastic thyroid carcinoma cell lines tested, but the highest levels of CDH1 mRNA were detected in the normal thyroid cell line while the anaplastic thyroid carcinoma cell line demonstrated the highest levels of SNAI2 and TWIST1 mRNA. Our findings support the role of epithelial-mesenchymal transition in the development of anaplastic thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22899291      PMCID: PMC3559085          DOI: 10.1038/modpathol.2012.137

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  22 in total

Review 1.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

2.  Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma.

Authors:  Sam M Wiseman; Hamid Masoudi; Paddy Niblock; Dmitry Turbin; Ashish Rajput; John Hay; Douglas Filipenko; David Huntsman; Blake Gilks
Journal:  Am J Surg       Date:  2006-05       Impact factor: 2.565

3.  Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion.

Authors:  Vasily Vasko; Allan V Espinosa; William Scouten; Huiling He; Herbert Auer; Sandya Liyanarachchi; Alexander Larin; Victoria Savchenko; Gary L Francis; Albert de la Chapelle; Motoyasu Saji; Matthew D Ringel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-12       Impact factor: 11.205

4.  Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.

Authors:  David Sarrió; Socorro María Rodriguez-Pinilla; David Hardisson; Amparo Cano; Gema Moreno-Bueno; José Palacios
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

5.  Snail family transcription factors are implicated in thyroid carcinogenesis.

Authors:  Robert G Hardy; Carolina Vicente-Dueñas; Ines González-Herrero; Catriona Anderson; Teresa Flores; Sharon Hughes; Chris Tselepis; James A Ross; Isidro Sánchez-García
Journal:  Am J Pathol       Date:  2007-09       Impact factor: 4.307

6.  Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer.

Authors:  Birgit Hotz; Marco Arndt; Sonja Dullat; Sarah Bhargava; Heinz-J Buhr; Hubert G Hotz
Journal:  Clin Cancer Res       Date:  2007-08-15       Impact factor: 12.531

Review 7.  The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies.

Authors:  Brett G Hollier; Kurt Evans; Sendurai A Mani
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-02-26       Impact factor: 2.673

8.  Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling.

Authors:  J A Knauf; M A Sartor; M Medvedovic; E Lundsmith; M Ryder; M Salzano; Y E Nikiforov; T J Giordano; R A Ghossein; J A Fagin
Journal:  Oncogene       Date:  2011-03-07       Impact factor: 9.867

9.  Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients.

Authors:  M Shioiri; T Shida; K Koda; K Oda; K Seike; M Nishimura; S Takano; M Miyazaki
Journal:  Br J Cancer       Date:  2006-06-19       Impact factor: 7.640

10.  In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines.

Authors:  Giovanni Zito; Pierina Richiusa; Alessandra Bommarito; Elvira Carissimi; Leonardo Russo; Antonina Coppola; Monica Zerilli; Vito Rodolico; Angela Criscimanna; Marco Amato; Giuseppe Pizzolanti; Aldo Galluzzo; Carla Giordano
Journal:  PLoS One       Date:  2008-10-28       Impact factor: 3.240

View more
  36 in total

1.  The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.

Authors:  Celina Montemayor-Garcia; Heather Hardin; Zhenying Guo; Carolina Larrain; Darya Buehler; Sofia Asioli; Herbert Chen; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

Review 2.  Novel approaches in anaplastic thyroid cancer therapy.

Authors:  Kun-Tai Hsu; Xiao-Min Yu; Anjon W Audhya; Juan C Jaume; Ricardo V Lloyd; Shigeki Miyamoto; Tomas A Prolla; Herbert Chen
Journal:  Oncologist       Date:  2014-09-26

Review 3.  Stem cells and cancer stem-like cells in endocrine tissues.

Authors:  Ricardo V Lloyd; Heather Hardin; Celina Montemayor-Garcia; Fabio Rotondo; Luis V Syro; Eva Horvath; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2013-03       Impact factor: 3.943

4.  Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway.

Authors:  C Visciano; F Liotti; N Prevete; G Cali'; R Franco; F Collina; A de Paulis; G Marone; M Santoro; R M Melillo
Journal:  Oncogene       Date:  2015-01-26       Impact factor: 9.867

5.  Long Non-coding RNA Expression in Anaplastic Thyroid Carcinomas.

Authors:  Yanping Wang; Heather Hardin; Ying-Hsia Chu; Karla Esbona; Ranran Zhang; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2019-12       Impact factor: 3.943

6.  Targeting of slug sensitizes anaplastic thyroid carcinoma SW1736 cells to doxorubicin via PUMA upregulation.

Authors:  Anbing Dong; Xuelong Jiao; Dong Chen; Fengyun Hao; Kejun Zhang
Journal:  Int J Biochem Mol Biol       Date:  2016-09-30

7.  MALAT1 Long Non-coding RNA Expression in Thyroid Tissues: Analysis by In Situ Hybridization and Real-Time PCR.

Authors:  Ranran Zhang; Heather Hardin; Wei Huang; Jidong Chen; Sofia Asioli; Alberto Righi; Francesca Maletta; Anna Sapino; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2017-03       Impact factor: 3.943

Review 8.  Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review.

Authors:  Heewa Shakib; Sadegh Rajabi; Mohammad Hossien Dehghan; Farideh Jalali Mashayekhi; Nahid Safari-Alighiarloo; Mehdi Hedayati
Journal:  Endocrine       Date:  2019-08-04       Impact factor: 3.633

9.  Twist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinoma.

Authors:  Nannan Lv; Zhongyan Shan; Yun Gao; Haixia Guan; Chenling Fan; Hong Wang; Weiping Teng
Journal:  Endocrine       Date:  2015-08-20       Impact factor: 3.633

10.  Expression of cancer stem cell markers and epithelial-mesenchymal transition-related factors in anaplastic thyroid carcinoma.

Authors:  Chang Won Jung; Kang Hee Han; Hyesil Seol; Sunhoo Park; Jae Soo Koh; Seung-Sook Lee; Min Joo Kim; Ik Joon Choi; Jae Kyung Myung
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.